Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/18/2026 | Q4 | $382.2M | -- | -- | $0.68 | -- |
| 11/05/2025 | Q3 | $300M | $327.9M | $0.70 | -$0.51 | $1.21 |
| 08/06/2025 | Q2 | $285.6M | $298.8M | $0.11 | -$0.36 | $0.47 |
| 04/30/2025 | Q1 | $284.6M | $298.2M | -$0.16 | -$0.23 | $0.07 |
| 02/13/2025 | Q4 | $306.7M | $297.5M | $0.02 | $0.46 | -$0.43 |
| 10/30/2024 | Q3 | $324M | $327.7M | $0.80 | $0.63 | $0.16 |
| 08/01/2024 | Q2 | $389.9M | $396.5M | $1.35 | $1.30 | $0.06 |
| 05/01/2024 | Q1 | $476.6M | $503.5M | $2.62 | $2.56 | $0.06 |
| 02/14/2024 | Q4 | $394.6M | $365M | $2.47 | $2.64 | -$0.16 |
| 11/01/2023 | Q3 | $366.9M | $423.5M | $1.64 | $1.71 | -$0.07 |
| 08/02/2023 | Q2 | -- | $379.7M | $1.58 | -- | -- |
| 05/03/2023 | Q1 | -- | $509.7M | $3.51 | -- | -- |
| 02/15/2023 | Q4 | -- | $344.8M | $1.93 | -- | -- |
| 11/02/2022 | Q3 | -- | $390.2M | $1.90 | -- | -- |
| 08/03/2022 | Q2 | -- | $625.2M | $5.74 | -- | -- |
| 05/05/2022 | Q1 | -- | $378.7M | $2.83 | -- | -- |
| 02/22/2022 | Q4 | -- | $415.5M | $2.69 | -- | -- |
| 11/02/2021 | Q3 | -- | $202.5M | $0.74 | -- | -- |
| 08/04/2021 | Q2 | -- | $227.4M | -$0.09 | -- | -- |
| 05/05/2021 | Q1 | -- | $213.8M | -$0.42 | -- | -- |
| 02/24/2021 | Q4 | -- | $212.3M | -$0.66 | -- | -- |
| 10/28/2020 | Q3 | -- | $180.1M | -$0.28 | -- | -- |
| 08/05/2020 | Q2 | -- | $163.7M | -$0.18 | -- | -- |
| 04/29/2020 | Q1 | -- | $226.7M | $0.42 | -- | -- |
| 02/19/2020 | Q4 | -- | $204.9M | $0.41 | -- | -- |
| 10/30/2019 | Q3 | -- | $287.5M | $0.87 | -- | -- |
| 07/31/2019 | Q2 | -- | $397.6M | $2.43 | -- | -- |
| 05/01/2019 | Q1 | -- | $378.3M | $2.14 | -- | -- |
| 02/21/2019 | Q4 | -- | $360.4M | $7.11 | -- | -- |
| 10/31/2018 | Q3 | -- | $273.3M | $1.00 | -- | -- |
| 08/01/2018 | Q2 | -- | $322.6M | $1.72 | -- | -- |
| 05/02/2018 | Q1 | -- | $421.8M | $3.36 | -- | -- |
| 02/14/2018 | Q4 | -- | $239.8M | $1.83 | -- | -- |
| 11/09/2017 | Q3 | -- | $312M | $2.27 | -- | -- |
| 08/03/2017 | Q2 | -- | $363.4M | $2.46 | -- | -- |
| 03/31/2017 | Q1 | -- | $254M | $2.06 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | $0.64 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.64 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$0.95 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$1.17 | -- | -- |
Warrior Met Coal, Inc. reported $327.9M worth of top line sales in its most recent quarter.
Warrior Met Coal, Inc. announced earnings per share of $0.70 which represents a beat of analyst forecast a -$0.51 per share.
Warrior Met Coal, Inc. reported $37.2M that represents $0.71 per share over the last quarter.
Warrior Met Coal, Inc.'s earnings are forecast to decrease from $4.79 per share to $5.21 per share next year representing a decrease of -72.23%.
Warrior Met Coal, Inc.'s next earnings date is February 18, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.